The former head of the IHU Méditerranée Infection in Marseille, now retired, is already accused of having conducted “wild” clinical trials on patients during the Covid epidemic.
:quality(50)/2023/07/06/64a68815cd1a7_placeholder-36b69ec8.png)
Published
Reading time: 1 min
:quality(50)/2024/09/05/000-328l8vj-66da1d720a90a450085156.jpg)
New attempt. A new publication by Professor Didier Raoult, accused of several breaches of ethics by many professionals since the Covid epidemic, has been reported to the National Agency for the Safety of Medicines and Health Products (ANSM) by the Assistance publique-Hôpitaux de Marseille (APHM) and the Fondation Méditerranée Infection (FMI), AFP learned from the APHM on Thursday, September 5, confirming information from the Point.
The incriminated study, published in the August 2024 edition of the journal “Acta Scientific Microbiology”, was co-signed by Didier Raoult, former head of the IHU Méditerranée Infection in Marseille, and one of his former close collaborators, Philippe Brouqui. The article, covering data from 1,276 Covid patients treated at the IHU, some of whom were treated with hydroxychloroquine, claims to once again demonstrate the effectiveness of this controversial treatment promoted by Didier Raoult.
In their letter, the APHM and the Mediterranean Infection Foundation, which oversees the IHU, “report” and “dissociate” of this article whose methodology is based on “the use of patient data and unauthorized research”specified the APHM. According to the establishment, this report was decided in a “logic of return to normal” at the IHU since the departure of Professor Raoult, now retired.
The ANSM had taken legal action in November 2023 after the publication of another study co-signed by Professor Raoult, which had not obtained the mandatory authorizations. The former head of the IHU and his team are suspected of having conducted several studies “savages” at the IHU during the Covid epidemic.
